Heritage Global Partners is auctioning pilot plant and late model laboratory equipment no longer required by Theravance Biopharma. South San Francisco and Dublin based Theravance Biopharma develops treatments for application in the fields of inflammation and immunology.
The online auction will open on the 22nd of May and bidding closes on the 23rd of May. The sale features mass spectrometers and HPLCs including Thermo Q Exactive HF-X LC/MS mass spectrometer, Sciex QTRAP 6500+ mass spectrometer, Agilent 6120 Quadrupole LC/MS with 1260 HPLC, Agilent 6130 Quadrupole LC/MS with 1260 HPLC, Thermo LTQ XL Mass Spc with Agilent 1260 HPLC, Agilent G6125B LC/MSD with 1260 HPLC. Laboratory equipment including: Labcyte Echo 550 acoustic liquid handler system, HighRes Biosolutions microplate processing workstation, Rigaku MiniFlex benchtop powder x-ray diffraction (XRD), Bruker D8 Advance x-ray diffraction (XRD), Essen Incucyte zoom system. Process development equipment including: (2) GL Filtration FD350-C22 filter dryers, Rousselet Robatel RC 30 VXR centrifuge, (4) Buchiglas chemReactor CR30-K high performance reactors, Buchiglasuster scrubber (170L capacity), Buchi R220 SE rotvapor and more.
The assets are located in South San Francisco, California and can be previewed by appointment with the auctioneer only.
Asset advisory and full-service auction firm Heritage Global Partners operates across more than 25 industries, including the oil and gas, pharmaceutical, automotive and food and beverage sectors. The firm conducts around 200 auctions every year – ranging from single asset dispositions to entire turnkey facilities and complete factories.
For further information about this, or any other Heritage Global Partners auction, please visit:
